Flemington Pharmaceutical Corp Sample Contracts

AutoNDA by SimpleDocs
Exhibit 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13G with respect to the shares of common stock of NovaDel Pharma Inc. is, and any amendment thereto signed by each of the undersigned shall be, filed on...
Joint Filing Agreement • December 2nd, 2005 • Novadel Pharma Inc • Pharmaceutical preparations

The undersigned hereby agree that the statement on Schedule 13G with respect to the shares of common stock of NovaDel Pharma Inc. is, and any amendment thereto signed by each of the undersigned shall be, filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended. The undersigned hereby further agree that this Joint Filing Agreement be included as an exhibit to such statement and any such amendment. This Joint Filing Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.

AGREEMENT
Joint Venture Agreement • September 26th, 2001 • Flemington Pharmaceutical Corp • Pharmaceutical preparations
WITNESSETH:
Warrant Agreement • October 3rd, 1997 • Flemington Pharmaceutical Corp • Pharmaceutical preparations • Delaware
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • February 10th, 2011 • Novadel Pharma Inc • Pharmaceutical preparations • New York

This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of February [___], 2011, is by and among NovaDel Pharma Inc., a Delaware corporation with headquarters located at 1200 Route 22 East, Suite 2000, Bridgewater, New Jersey 08807 (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).

WITNESSETH:
Warrant Agreement • October 31st, 1997 • Flemington Pharmaceutical Corp • Pharmaceutical preparations • Delaware
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • February 15th, 2011 • Novadel Pharma Inc • Pharmaceutical preparations • New York

This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of February 14, 2011, is by and among NovaDel Pharma Inc., a Delaware corporation with headquarters located at 1200 Route 22 East, Suite 2000, Bridgewater, New Jersey 08807 (the ”Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).

AutoNDA by SimpleDocs
EXHIBIT 10.34 EXECUTION COPY: NOV 18, 2004 MANUFACTURING AND SUPPLY AGREEMENT DATED 18 NOVEMBER, 2004 INYX USA, LTD
Manufacturing and Supply Agreement • December 15th, 2004 • Novadel Pharma Inc • Pharmaceutical preparations
THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUED UPON ITS EXERCISE ARE SUBJECT TO THE RESTRICTIONS ON TRANSFER SET FORTH IN SECTION 5 OF THIS WARRANT
Common Stock Purchase Warrant • January 4th, 2007 • Novadel Pharma Inc • Pharmaceutical preparations • New York

NovaDel Pharma Inc., a Delaware corporation (the “Company”), for value received, hereby certifies that [ ], or its registered assigns (the “Registered Holder”), is entitled, subject to the terms and conditions set forth below, to purchase from the Company, at any time or from time to time on or after the date that is 6 months after date of issuance and on or before 5:00 p.m. (Eastern time) on [ ], 2011 (the “Exercise Period”), [ ] shares of Common Stock, $0.001 par value per share, of the Company (“Common Stock”), at a purchase price of $1.70 per share. The shares purchasable upon exercise of this Warrant, and the purchase price per share, each as adjusted from time to time pursuant to the provisions of this Warrant, are hereinafter referred to as the “Warrant Shares” and the “Purchase Price,” respectively. This Warrant is one of a series of Warrants issued by the Company in connection with a private placement of Common Stock and of like tenor, except as to the number of shares of Comm

FORM OF SERIES B WARRANT] NOVADEL PHARMA INC. WARRANT TO PURCHASE COMMON STOCK
Warrant to Purchase Common Stock • February 15th, 2011 • Novadel Pharma Inc • Pharmaceutical preparations • New York

NovaDel Pharma Inc., a Delaware corporation (the “Company”), hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, [IROQUOIS MASTER FUND LTD.], [OTHER BUYERS], the registered holder hereof or its permitted assigns (the “Holder”), is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, upon exercise of this Warrant to Purchase Common Stock (including any Warrants to Purchase Common Stock issued in exchange, transfer or replacement hereof, the “Warrant”), at any time or times on or after the Issuance Date, but not after 11:59 p.m., New York time, on the Expiration Date (as defined below), [______________]1 (subject to adjustment as provided herein) fully paid and non-assessable shares of Common Stock (as defined below) (the “Warrant Shares”). Except as otherwise defined herein, capitalized terms in this Warrant shall have the meanings set f

FORM OF SERIES B WARRANT] NOVADEL PHARMA INC. WARRANT TO PURCHASE COMMON STOCK
Warrant Agreement • March 31st, 2010 • Novadel Pharma Inc • Pharmaceutical preparations • New York

Novadel Pharma Inc., a Delaware corporation (the “Company”), hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, [IROQUOIS MASTER FUND LTD.][OTHER BUYERS], the registered holder hereof or its permitted assigns (the “Holder”), is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, upon exercise of this Warrant to Purchase Common Stock (including any Warrants to Purchase Common Stock issued in exchange, transfer or replacement hereof, the “Warrant”), at any time or times on or after the Issuance Date, but not after 11:59 p.m., New York time, on the Expiration Date (as defined below), [______________]1 (subject to adjustment as provided herein) fully paid and nonassessable shares of Common Stock (as defined below) (the “Warrant Shares”). Except as otherwise defined herein, capitalized terms in this Warrant shall have the meanings set fort

COMMON STOCK PURCHASE AGREEMENT
Common Stock Purchase Agreement • June 30th, 2009 • Novadel Pharma Inc • Pharmaceutical preparations • New York

This Common Stock Purchase Agreement (this “Agreement”) is dated as of June 26, 2009, by and between NovaDel Pharma Inc., a Delaware corporation (the “Company”), and Seaside 88, LP, a Florida limited partnership (such investor, including its successors and assigns, “Seaside”).

AGREEMENT
Exclusive Marketing Agreement • September 26th, 2001 • Flemington Pharmaceutical Corp • Pharmaceutical preparations
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • May 27th, 2005 • Novadel Pharma Inc • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of May 26, 2005, among NovaDel Pharma Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

EMPLOYMENT AGREEMENT
Employment Agreement • December 8th, 2006 • Novadel Pharma Inc • Pharmaceutical preparations • New Jersey

AGREEMENT (the “Agreement”), dated as of December 4, 2006 by and between NOVADEL PHARMA INC., a Delaware corporation with principal executive offices at 25 Minneakoning Rd., Flemington, New Jersey 08822 (the “Company”), and DAVID H. BERGSTROM, Ph.D. residing at 15 Kerby Lane, Mendham, New Jersey 07945-2901 (the “Executive”).

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!